Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05804331 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

Name: The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study — clinical trial record (NCT05804331)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ANZ UGI

StatusRecruiting

PhaseNot specified

SponsorWestern Sydney Local Health District

Started2023-03-14

View on ClinicalTrials.gov ↗

Amendment history

2025-03-25

Study Status, Contacts/Locations v2

Study sitescontacts updated at 1 of 1 site

2024-07-22

Study Status v1

Re-verified, no change to tracked fields

2023-03-26

Original filing

Western Sydney Local Health District

18 trials monitored

See 1 trial at risk

Gastric Cancer

1,194 trials monitored

See 60 trials at risk

Esophageal Cancer

1,010 trials monitored

See 51 trials at risk

To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions

Trial Details

NCT Number	NCT05804331
Lead Sponsor	Western Sydney Local Health District
Conditions	Cancer of Stomach, Oesophageal Cancer, Gastric Cancer, Gastric Adenocarcinoma, GI Cancer, GIST, Neuroendocrine Tumors, Gastric Neoplasm +1 more
Enrollment	500 participants
Start Date	2023-03-14
Primary Completion	2028-03-14 (estimated)
Study Completion	2028-09-14 (estimated)
Updated on ClinicalTrials.gov	2025-03-27